Kasmintan Schrader

Dr. Kasmintan Schrader obtained her medical degree from the University of Melbourne and completed her Medical Genetics residency at the University of British Columbia, Canada. During her graduate studies, she undertook the Royal College of Physicians and Surgeons of Canada Clinician Investigator Program in the Department of Pathology and Laboratory Medicine.

Dr. Schrader was supported by the Canadian Institutes of Health and Research training award at Memorial Sloan Kettering Cancer Center in New York where she co-identified PAX5 as a novel susceptibility gene for Pre-B cell acute lymphoblastic leukemia.

She is an assistant professor in the Department of Medical Genetics at the UBC, a scientist at BC Cancer Research Institute, and a clinical geneticist at BC Cancer’s Hereditary Cancer Program. Dr. Schrader serves as co-medical Director of BC Cancer’s provincial Hereditary Cancer Program, co-chair of the Personalized OncoGenomics Policy and Ethics working group, co-chair of the ClinGen CDH1 Variant Curation Expert Panel and holds a Tier 2 Canada Research Chair in Clinical Cancer Genetics and Genomics.

Recent publications.